• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Silo Pharma, Inc. - Common Stock (NQ:SILO)

    0.3608 -0.0007 (-0.19%)
    Streaming Delayed Price Updated: 12:13 PM EST, Jan 21, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about Silo Pharma, Inc. - Common Stock

    < Previous 1 2 3 4 5 6 7 Next >
    News headline image
    Silo Pharma Executes Letter of Intent with Allucent to Support Phase 1 Clinical Development of SPC-15
    From Silo Pharma, Inc.
    Via GlobeNewswire
    News headline image
    Silo Pharma Partners with Allucent to Support Planned FDA Investigational New Drug Application for SPC-15 as a Therapeutic for PTSD
    From Silo Pharma, Inc.
    Via GlobeNewswire
    News headline image
    Silo Pharma Selects Alphaledger’s T12 Fund for Tokenized Real-World Asset Investments on Solana Blockchain
    From Silo Pharma, Inc.
    Via GlobeNewswire
    News headline image
    Silo Pharma Issues Update on Milestone Achievements in PTSD Drug Development and New Digital Assets Treasury Program
    From Silo Pharma, Inc.
    Via GlobeNewswire
    News headline image
    Silo Pharma Expands Crypto Treasury with First Strategic Bitcoin Purchase Reinforcing Company’s Commitment to Multi-Chain Growth
    From Silo Pharma, Inc.
    Via GlobeNewswire
    News headline image
    Silo Pharma Acquires ResearchCoin (RSC) Crypto Tokens in Support of Decentralized Science (DeSci)
    From Silo Pharma, Inc.
    Via GlobeNewswire
    News headline image
    Silo Pharma Announces Closing of $2.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
    From Silo Pharma, Inc.
    Via GlobeNewswire
    News headline image
    Silo Pharma Announces $2.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
    From Silo Pharma, Inc.
    Via GlobeNewswire
    News headline image
    Silo Pharma Updates Strategic Agreement with Fireblocks to Secure Crypto Treasury Management
    From Silo Pharma, Inc.
    Via GlobeNewswire
    News headline image
    Silo Pharma Signs Strategic Agreement with Fireblocks to Advance Crypto Treasury Strategy Acquisition and Security
    Highly secure, institutional-grade infrastructure supports Bitcoin, Ethereum and Solana treasury strategy 
    From Silo Pharma, Inc.
    Via GlobeNewswire
    News headline image
    Silo Pharma Announces Initial Investment in Ethereum and Solana under Cryptocurrency Treasury Strategy
    From Silo Pharma, Inc.
    Via GlobeNewswire
    News headline image
    Silo Pharma Adds Japanese Patent to Expanding Global IP Portfolio for Licensed PTSD Drug
    From Silo Pharma, Inc.
    Via GlobeNewswire
    News headline image
    Silo Pharma Secures Australian Patent Covering Licensed PTSD Drug Candidate Expanding Global IP Portfolio
    From Silo Pharma, Inc.
    Via GlobeNewswire
    News headline image
    Silo Pharma’s Alzheimer’s Candidate SPC-14 Featured in Leading Scientific Peer-reviewed Journal
    From Silo Pharma, Inc.
    Via GlobeNewswire
    News headline image
    Silo Pharma’s PTSD Candidate SPC-15 Achieves Positive Safety Milestone, Paving Way for Accelerated Clinical Trials Under 505(b)(2) Pathway
    From Silo Pharma, Inc.
    Via GlobeNewswire
    News headline image
    Silo Pharma Appoints Crypto Infrastructure Pioneer Corwin Yu to Launch Institutional Bitcoin, Ethereum and Solana Treasury Platform
    From Silo Pharma, Inc.
    Via GlobeNewswire
    News headline image
    Silo Pharma Announces Completion of Dosing in Safety Study of PTSD Drug SPC-15
    From Silo Pharma, Inc.
    Via GlobeNewswire
    InvestorNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Expects SPC-15 PTSD Study Results Within 90 Days
    Via Investor Brand Network
    News headline image
    Silo Pharma Advances PTSD Drug SPC-15 Toward Planned 2025 IND Submission with Pre-Clinical Study Data Expected in Q3 2025
    From Silo Pharma, Inc.
    Via GlobeNewswire
    News headline image
    Silo Pharma Enters into Letter of Intent to Form Joint Venture with Hoth Therapeutics to Develop Obesity Treatment Targeting $16 Billion Global Market
    Via Get News
    Topics Intellectual Property
    News headline image
    Silo Pharma Enters into Letter of Intent to Form Joint Venture with Hoth Therapeutics to Develop Obesity Treatment Targeting $16 Billion Global Market
    From Silo Pharma, Inc.
    Via GlobeNewswire
    News headline image
    Silo Pharma Enters into Letter of Intent to Form Joint Venture with Hoth Therapeutics to Develop Obesity Treatment Targeting $16 Billion Global Market
    Via Press Release Distribution Service
    Topics Intellectual Property
    PsychedelicNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Receives USPTO Notice of Allowance for PTSD Treatment Patent
    Via Investor Brand Network
    Topics Intellectual Property
    News headline image
    Silo Pharma Secures Biomarker Patent for Novel PTSD Therapeutic SPC-15 as Clinical Trial Nears
    From Silo Pharma, Inc.
    Via GlobeNewswire
    News headline image
    Silo Pharma Board of Directors Approves Purchase of Bitcoin as Treasury Reserve Asset
    Strategic decision positions Company to diversify treasury holdings with a long-term digital store of value 
    From Silo Pharma, Inc.
    Via GlobeNewswire
    InvestorNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Advances PTSD Treatment with Nasal Spray Device Study for SPC-15
    Via Investor Brand Network
    News headline image
    Silo Pharma Partners with Resyca for IND-Supporting Intranasal Drug-Device Study of PTSD Drug SPC-15
    Study is expected to deliver final device data and documentation needed for planned FDA IND submission 
    From Silo Pharma, Inc.
    Via GlobeNewswire
    InvestorNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Closes $2 Million Public Offering of Shares and Warrants
    Via Investor Brand Network
    News headline image
    Silo Pharma Announces Closing of $2 Million Public Offering
    From Silo Pharma, Inc.
    Via GlobeNewswire
    InvestorNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Prices $2 Million Public Offering of Common Stock and Warrants
    Via Investor Brand Network
    < Previous 1 2 3 4 5 6 7 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.